Clinical Trial Update: Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Limtop, a topical Imiquimod formulation, used 1, 3, or 7 times weekly for two 2-week periods to treat actinic keratosis on the head, as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Limtop (Imiquimod)

Snippet

Sponsor: Moberg Pharma AB | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED